What role does CYP1A2 play in menopause?

CYP1A2 is a cytochrome P450 enzyme involved in estrogen metabolism, particularly converting estradiol to 2-hydroxyestrone (a protective metabolite) and 4-hydroxyestrone (potentially genotoxic). During menopause, declining estrogen levels may alter CYP1A2 activity, with some studies suggesting reduced enzyme function postmenopause. Additionally, lifestyle factors like smoking and caffeine intake induce CYP1A2, and genetic variants (e.g., rs762551) classify individuals as fast or slow metabolizers. However, direct evidence linking CYP1A2 to menopausal symptoms or disease risk is limited and mostly mechanistic. The enzyme's role in drug metabolism (e.g., clozapine, theophylline) is better established. A DNA test can indicate metabolic phenotype, but clinical decisions should involve a healthcare provider. Women on hormone therapy or medications metabolized by CYP1A2 should be aware of potential changes during menopause.